Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-09 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-00 |
filingDate |
2003-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2006505606-A |
titleOfInvention |
Process for converting cis-trans mixtures of substituted benzylidene amines into pure cis isomers |
abstract |
A process for the interconversion of a cis-trans erythro-threo isomer mixture of a compound of formula I into a substantially pure cis isomer. The cis isomers of formula I are useful intermediates in the synthesis of cis isomers of benzamide piperidine compounds that exhibit activity as NK-1 receptor antagonists. [Chemical 1] |
priorityDate |
2002-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |